ACE2 and COVID-19: Studies have shown that statins are correlated with significantly lower mortality in patients with COVID-19, thought to be due in part to blood-lipid reduction which may interfere with viral entry into the lipid membrane of the host cell as well as the anti-inflammatory effects of ACE-2 upregulation [37].